莫亚莫亚病相关动脉瘤的分类和治疗策略
Yangchun Hu1, Xiaojian Wang1, Chao Li1
1Department of Neurosurgery, The First Affiliated Hospital of Anhui Medical University, Jixi 218, Hefei, 230022, People's Republic of China.
Chinese neurosurgical journal
|December 21, 2023
概括
带有内动脉瘤的莫亚莫亚病 (MMD-IA) 呈现出不同的临床特征. 基于动脉瘤位置的个性化神经外科治疗对于MMD-IA患者的成功结果至关重要.
科学领域:
- 神经学 神经学
- 神经外科 神经外科
- 血管神经学 血管神经学
背景情况:
- 莫亚莫亚病 (MMD) 涉及远端内动脉的渐进性狭窄.
- 在MMD的血液动力学变化可以导致内动脉瘤 (IA) 的并发症.
- 这项研究研究了Moyamoya病与内动脉瘤 (MMD-IA) 的临床特征和治疗方法.
研究的目的:
- 分析MMD-IA患者的临床表现.
- 评估MMD-IA的治疗策略.
- 根据动脉瘤的位置来确定最佳的治疗方法.
主要方法:
- 对13名出现内出血的MMD-IA患者的回顾性审查.
- 对所有患者的手术技术笔记的分析.
- 根据位置对动脉瘤的分类:威利斯圆圈,侧面瘤或基底腺区域.
主要成果:
- 动脉瘤的位置包括威利斯圆 (10名患者),周围动脉 (2名患者) 和基底腺 (1名患者).
- 治疗包括内血管栓塞 (5名患者) 和动脉瘤切割 (7名患者).
- 一名患有基底腺动脉瘤的患者接受了再血管化;所有治疗都成功,在6-24个月的随访中取得了令人满意的结果.
结论:
- MMD-IA 呈现出不同的临床表现.
- 对MMD-IA的治疗策略应根据特定的动脉瘤位置进行个性化.
- 定制的神经外科干预对于有效管理MMD-IA至关重要.
相关概念视频
Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Aneurysm I: Introduction
An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
Aneurysm III: Interprofessional Care
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Aneurysm IV: Nursing Management
Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...


